These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26060418)

  • 1. Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody.
    Sato R; Hamada N; Kashiwagi T; Imamura Y; Hara K; Nishimura M; Kamimura T; Takasaki T; Watanabe H; Koga T
    Trop Med Health; 2015 Jun; 43(2):85-8. PubMed ID: 26060418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection.
    Kotaki T; Nagai Y; Yamanaka A; Konishi E; Kameoka M
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.
    Anderson KB; Gibbons RV; Thomas SJ; Rothman AL; Nisalak A; Berkelman RL; Libraty DH; Endy TP
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1311. PubMed ID: 21991398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of dengue, Japanese encephalitis and Zika among long-term expatriates in Thailand.
    Kitro A; Imad HA; Pisutsan P; Matsee W; Sirikul W; Sapbamrer R; Rapheal E; Fernandez S; Cotrone TS; Farmer AR; Hunsawong T; Silachamroon U; Chatapat L; Olanwijitwong J; Salee P; Anderson KB; Piyaphanee W
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38335250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
    Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Winners of globalization: dengue viruses and Japanese encephalitis virus-Diseases in neurology].
    Meyding-Lamadé U; Craemer EM
    Nervenarzt; 2018 Dec; 89(12):1338-1343. PubMed ID: 30251003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients.
    Bundo K; Igarashi A
    J Virol Methods; 1985 May; 11(1):15-22. PubMed ID: 2989309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus.
    Yunoki M; Kurosu T; Koketsu RK; Takahashi K; Okuno Y; Ikuta K
    Biologics; 2016; 10():99-102. PubMed ID: 27462140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and disease burden of children hospitalized for viral infections within the family Flaviviridae in China: A national cross-sectional study.
    Wang R; Wang X; Zhang L; Feng G; Liu M; Zeng Y; Xie Z
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010562. PubMed ID: 35788743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue hemorrhagic fever in an adult traveler returning to Japan.
    Goto K; Hatakeyama S; Okamoto K; Kitazawa T; Abe K; Moriya K; Koike K; Yotsuyanagi H
    Intern Med; 2012; 51(13):1779-82. PubMed ID: 22790145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes.
    Pushpakumara PD; Jeewandara C; Wijesinghe A; Gomes L; Ogg GS; Goonasekara CL; Malavige GN
    Front Public Health; 2020; 8():19. PubMed ID: 32117854
    [No Abstract]   [Full Text] [Related]  

  • 17. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H; Mosso C; Medina F; Liprandi F; Ludert JE; del Angel RM
    J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.